The effectiveness of inodilators in reducing short term mortality among patient with severe cardiogenic shock: a propensity-based analysis.
<h4>Background</h4>The best catecholamine regimen for cardiogenic shock has been poorly evaluated. When a vasopressor is required to treat patients with the most severe form of cardiogenic shock, whether inodilators should be added or whether inopressors can be used alone has not been es...
Guardado en:
Autores principales: | Romain Pirracchio, Jiri Parenica, Matthieu Resche Rigon, Sylvie Chevret, Jindrich Spinar, Jiri Jarkovsky, Faiez Zannad, François Alla, Alexandre Mebazaa, GREAT network |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/baef87c834574cb586b2389c6ab2b64d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Contemporary Cardiogenic Shock ‘Playbook’
por: Alexander G Truesdell
Publicado: (2021) -
Cardiogenic Shock: Protocols, Teams, Centers, and Networks
por: Alex F Warren, et al.
Publicado: (2021) -
Editorial: Cardiogenic Shock: Basic and Clinical Considerations
por: Deepak Acharya, et al.
Publicado: (2021) -
Extracorporeal Life Support for Cardiac Arrest and Cardiogenic Shock
por: Andrea Elliott, et al.
Publicado: (2021) -
Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
por: Petr Lokaj, et al.
Publicado: (2021)